Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prothrombotic factors in stroke].

E Meseguer1, P Llamas, J Fernández de Velasco

  • 1Servicio Neurología, Fundación Jiménez Díaz, Madrid.

Neurologia (Barcelona, Spain)
|April 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxic and DNA-topoisomerase effects of lapachol amine derivatives and interactions with DNA.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2007
Same author

Amidine derivatives and Leishmania amazonensis: an evaluation of the effect of nitric oxide (NO) production on the parasite-macrophage interaction.

Journal of enzyme inhibition and medicinal chemistry·2005
Same author

Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma.

British journal of cancer·2004
Same author

DNA topoisomerase inhibitors: biflavonoids from Ouratea species.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2002
Same author

Protein kinase A of Leishmania amazonensis as a potential target for methoxy-amidine.

Arzneimittel-Forschung·2002
Same author

A solid-state NMR, X-ray diffraction, and ab initio computational study of hydrogen-bond structure and dynamics of pyrazole-4-carboxylic acid chains.

Journal of the American Chemical Society·2001

Prothrombin 20210A gene mutation may increase stroke risk in individuals under 60. Factor V Leiden polymorphism showed no association with stroke in this case-control study.

Area of Science:

  • Genetics and Thrombosis
  • Neurology and Cerebrovascular Disease

Context:

  • Factor V Leiden and prothrombin 20210A are common thrombophilia mutations.
  • Their association with stroke, particularly in younger individuals, remains debated.

Purpose:

  • To investigate the relationship between Factor V Leiden and prothrombin 20210A polymorphisms and stroke.
  • To analyze these associations based on patient age and stroke subtype.

Summary:

  • A case-control study analyzed 312 stroke cases and controls.
  • Prothrombin 20210A showed a potential association with stroke in patients under 60 (OR: 2.92).
  • Factor V Leiden was not associated with stroke across any age group or stroke subtype.

Impact:

Related Experiment Videos

  • Suggests prothrombin 20210A may be a risk factor for stroke in younger populations.
  • Highlights the need for further research into genetic predispositions for stroke.
  • Provides evidence that Factor V Leiden is unlikely to be a significant risk factor for stroke.